Novavax (NASDAQ:NVAX) has a new man heading its finance team. That individual is Barclay "Buck" Phillips, who in addition to being CFO will also hold the position of senior vice president. The appointment is effective immediately.
Prior to coming to Novavax, Phillips filled the same roles at Micromet, which in January 2012 was acquired by Amgen. He also served as managing director at privately held Vector Fund Management and as an analyst and director of venture investments at Invesco.
In the press release announcing the appointment, Novavax quoted CEO Stanley Erck as saying that Phillips' insights "will be invaluable as we continue to develop and expand our pipeline of vaccine candidates and move toward commercial operations."
Fool contributor Eric Volkman has no position in any stocks mentioned, and neither does The Motley Fool. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
3 Biotech Stocks That Soared This Week: Are They Buys?
These three small biotech stocks saw huge jumps. Can their momentum continue?
3 Top Growth Stocks to Buy in January
If you're searching for top growth stocks in this heated market, these three stocks are worth checking out.
Why Eastman Kodak, Novavax, and Alamos Gold Slumped Today
These stocks fell despite a good day for Wall Street. Find out why.